Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia

Europe & Central Asia: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and was 20.7% in 2021. ▼ Falling

Latest (2021)
20.7%
Change on year
down 2.7%
Rank
37th
of 47 groups
All-time high
31.2%
in 2000
All-time low
20.7%
in 2021
Years of data
22
2000–2021

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia, 2000–2021

01020302000201020212000: 31.2 %2001: 30.6 %2002: 30.5 %2003: 30.2 %2004: 29.4 %2005: 29.3 %2006: 28.2 %2007: 27.5 %2008: 27 %2009: 26.4 %2010: 25.8 %2011: 24.9 %2012: 24.3 %2013: 23.8 %2014: 23.9 %2015: 23.3 %2016: 23 %2017: 22.5 %2018: 22.5 %2019: 21.9 %2020: 21.3 %2021: 20.7 %

Source: World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Measured in %.

Analysis

In 2021, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia stood at 20.7%. That is the lowest value across all 22 years on record.

The figure is down 2.7% on the previous year and down 16.8% over ten years.

Over the whole period, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia peaked at 31.2% in 2000 and was at its lowest, 20.7%, in 2021.

Europe & Central Asia ranks 37th of 47 groups on this measure, in the bottom quarter.

The long-run direction has been consistently falling across the 22 years of available data.

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia, year by year

Annual values for Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%) in Europe & Central Asia, 2000 to 2021.
Year % Change
2000 31.2%
2001 30.6% -1.8%
2002 30.5% -0.4%
2003 30.2% -1.0%
2004 29.4% -2.6%
2005 29.3% -0.3%
2006 28.2% -3.8%
2007 27.5% -2.6%
2008 27.0% -1.7%
2009 26.4% -2.4%
2010 25.8% -2.2%
2011 24.9% -3.3%
2012 24.3% -2.4%
2013 23.8% -2.3%
2014 23.9% +0.4%
2015 23.3% -2.4%
2016 23.0% -1.0%
2017 22.5% -2.3%
2018 22.5% -0.2%
2019 21.9% -2.8%
2020 21.3% -2.5%
2021 20.7% -2.7%

Averages by decade

DecadeAverage LowestHighest Years
2000s 29.0% 26.4% 31.2% 10
2010s 23.6% 21.9% 25.8% 10
2020s 21.0% 20.7% 21.3% 2

Countries ranked near Europe & Central Asia

  1. 35 Guinea-Bissau 28.2% compare
  2. 36 Somalia 28.1% compare
  3. 37 Kazakhstan 28.0% compare
  4. 37 Yemen 28.0% compare
  5. 39 Togo 27.9% compare
  6. 40 Vietnam 27.7% compare

See the full ranking of 232 places →

More health data for Europe & Central Asia

All data for Europe & Central Asia →

Frequently asked questions

What is mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia?
Mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Europe & Central Asia was 20.7% in 2021, according to World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO).
What is the highest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Europe & Central Asia?
The highest recorded value was 31.2% in 2000.
What is the lowest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Europe & Central Asia?
The lowest recorded value was 20.7% in 2021.
How does Europe & Central Asia rank for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
Europe & Central Asia ranks 37th out of 47 groups with data for 2021.
Is mortality from cvd, cancer, diabetes or crd between exact ages 30 and rising or falling in Europe & Central Asia?
Over the last ten years it is down 16.8%. The long-run trend across the full record is falling.
Where does this Europe & Central Asia data come from?
The figures come from World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as part of Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia. Statizoid, drawing on World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Retrieved 17 September 2026, from https://health.statizoid.com/stat/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-male-percent/europe-and-central-asia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-male-percent/europe-and-central-asia/">Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Europe & Central Asia</a> — Statizoid

About this data

Indicator
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%)
Unit
%
Source
World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 5,104 data points, 2000–2021
Last refreshed

Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).